ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2018 American Transplant Congress

    Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures

    L. Chen,1 D. Kamiyama,2 L. Francalacci,1 E. Zhu,2 M. Donnelley,2 N. Clayton,2 K. Alman,1 A. De Mattos,1 J. Brown.3

    1Transplant Nephrology, UC Davis Medical Center, Sacramento, CA; 2Pharmacy, UC Davis Medical Center, Sacramento, CA; 3Infectious Diseases, UC Davis Medical Center, Sacramento, CA.

    OBJECTIVES: To evaluate outcomes in renal transplant recipients who received organs from donors with positive blood or urine cultures.METHODS: We performed a retrospective, single-center study…
  • 2017 American Transplant Congress

    Calibration of BK Virus Nucleic Acid Amplification Testing to the 1st WHO International Standard for BK Virus.

    S. Tan,1 S. Milligan,2 M. Sahoo,3 N. Taylor,2 B. Pinsky.1,2,3

    1Department of Medicine, Division of Infectious Diseases, Stanford University School of Medicine, Stanford, CA; 2Clinical Virology Laboratory, Stanford Health Care, Stanford, CA; 3Department of Pathology, Stanford University School of Medicine, Stanford, CA

    Significant inter-assay variability in the quantification of BK virus (BKV) DNA has limited the broad applicability of thresholds for the management of BKV infection in…
  • 2017 American Transplant Congress

    Kidney Transplant Allocation with CMV Matching Reduces CMV Infection and Related Costs.

    J. Lockridge,1 E. Langewisch,2 D. Basuli,1 A. Olyaei,3 C. Shaut,4 D. Norman.1

    1Division of Nephrology, Department of Medicine, Oregon Health and Science University, Portland, OR; 2Nephrology, University of Nebraska, Omaha, NE; 3Pharmacy, Oregon Health and Sciences University, Portland, OR; 4Immunogenetics and Transplant, Oregon Health and Sciences University, Portland, OR

    Cytomegalovirus (CMV) infection is a major cause of morbidity, mortality, and shortened graft survival in kidney transplant recipients. Efforts to prevent CMV infection have traditionally…
  • 2017 American Transplant Congress

    CMV-Specific CD4+ T Cells in CMV-IgG-Seronegative Individuals Protect from CMV Viremia Following Transplantation with a CMV-Seropositive Donor Kidney.

    N. Litjens, L. Huang, B. Dedeoglu, R. Meijers, M. Betjes.

    Internal Medicine, Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, Netherlands

    A primary infection with cytomegalovirus (CMV) is one of the major threats following transplantation of a CMV-IgG-seropositive donor organ into a CMV-IgG-seronegative individual. Therefore, prophylactic…
  • 2017 American Transplant Congress

    Identifying Risks and Screening Deceased Organ Donors in the UK for Trypanosoma cruzi .

    I. Ushiro-Lumb,1,2 M. Webster,1 A. Kitchen.1

    1Microbiology Services, NHS Blood and Transplant, London, United Kingdom; 2Virus Reference Department, Public Health England, London, United Kingdom

    Background: In the UK, the Advisory Committee on Microbiological Safety of Blood, Tissues and Organs recommends discretionary T. cruzi antibody screening of donors with identified…
  • 2017 American Transplant Congress

    Liver Transplantation Outcomes Using Anti-Thymocyte Globulin Induction in Patients with Autoimmune Hepatitis.

    S. LeCorchick, A. Sharma, I. Yakubu, C. Bhati, T. Reichman, L. Kang, M. Levy.

    Transplantation Surgery, Virginia Commonwealth University, Richmond, VA

    Background: The use of rabbit anti-thymocyte globulin (ATG) induction in high immunological risk patients with autoimmune hepatitis (AIH) could lower the rejection rates after liver…
  • 2017 American Transplant Congress

    Early Acute Cellular Rejection(eACR) as a Marker of Immunologic Competency Following Liver Transplantation(LT).

    V. Kirchner, A. Bandgdiwala, D. Vock, M. Hassan, R. Kandaswamy, J. Lake, N. Lim, A. Mahgoub, E. Minja, A. Pugalenthi, B. Sengupta, O. Serrano, J. Thompson, W. Payne, T. Pruett, S. Chinnakotla.

    University of Minnesota, Minneapolis, MN

    Background:Historically eACR did not adversely impact patient survival(PS). Since infection(Ifx) is major cause of death(COD) among LT recipients, we hypothesized that eACR is marker of…
  • 2017 American Transplant Congress

    De Novo DSA Positivity Is Associated with a Higher Rate of Post-Transplant Bacterial and Viral Infections.

    A. Brooks,1 L. Rebellato,2 K. Briley,2 P. Bolin,2 S. Kendrick,3 A. Maldonado,4 C. Haisch,2 M. Everly.1

    1Terasaki Foundation Laboratory, Los Angeles; 2East Carolina University, Greenville, NC; 3Eastern Nephrology Associates, Greenville, NC; 4Vidant Medical Center, Greenville, NC

    Background: BK viremia has been shown to correlate with de novo anti-HLA DSA (dnDSA) in renal transplant patients. However, it is unknown if and how…
  • 2017 American Transplant Congress

    Increased T Cell Exhaustion in Dialysis Patients.

    M. Bastiaansen, A. Uffing, L. Riella.

    Transplantation Research Center, Brigham and Women's Hospital, Boston, MA

    Infection is a major complication post-transplantation. Evaluating the immune system prior to transplant may allow better optimization of immunosuppression dose. T cell exhaustion has been…
  • 2017 American Transplant Congress

    Strongyloides Infection in Solid Organ Transplant Recipients: A Single Center Experience and Review of the Literature.

    H. El Haddad,1 V. Hemmige,1 A. Sofjan,2 T. Lasco,3 A. Restrepo.1

    1Dept. of Medicine, Div. of Infectious Diseases, Baylor College of Medicine, Houston, TX; 2Univ. of Houston, College of Pharmacy, Houston, TX; 3CHI Baylor St Luke's Medical Center, Houston, TX

    Background: Solid Organ Transplant (SOT) recipients are at risk for Strongyloides stercoralis hyperinfection syndrome and disseminated disease. Most cases are caused by reactivation of latent…
  • « Previous Page
  • 1
  • …
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences